18 completed, 10 recruiting, 9 unknown, 6 active not recruiting. 13 Phase 3, 11 Phase 2, 3 Not applicable, 3 Phase 4, 1 Early Phase 1.
Follow Pericarditis: new trials by email Literature Review of Pericarditis trials Research Report on Pericarditis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pericardial Imaging Study 18F-FDG PET/CT - Pericarditis | Phase 3 | Not yet recruiting | Ottawa Heart Institute Research Corporation | 44 | 2026-12-01 | 2026-05-01 |
| Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research Pericarditis, Tako-TSUBO Cardiomyopathy | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 300 | 2026-09-01 | 2026-08-10 | |
| Transition to KPL-387 Monotherapy Dosing & Administration Study KPL-387 - Recurrent Pericarditis, Heart Diseases | Phase 2 | Recruiting | Kiniksa Pharmaceuticals International, plc | 120 | 2026-03-25 | 2026-10-20 |
| Effects of Pulmonary Rehabilitation Versus Standard Care in Patients With Pericarditis Pulmonary Rehabilitation, Standard Care - Pericarditis | Not applicable | Active not recruiting | University of Lahore | 60 | 2025-12-11 | 2026-07-21 |
| Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis RPH-104, Placebo - Recurrent Pericarditis | Phase 2 / Phase 3 | Suspended | R-Pharm Overseas, Inc. | 80 | 2025-12-01 | 2024-11-15 |
| EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases observational study - Myocarditis, ANCA Associated Vasculitis | Recruiting | Assistance Publique - Hôpitaux de Paris | 5000 | 2025-11-19 | 2026-06-05 | |
| Multimodal Analysis of Endomyocardial Biopsies Heart Transplantation, Dilated Cardiomyopathy (DCM) | Recruiting | University Hospital, Essen | 216 | 2025-10-27 | 2026-01-22 | |
| CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome Camptodactyly, Arthropathy | Recruiting | Meyer Children's Hospital IRCCS | 15 | 2025-08-01 | 2026-03-16 | |
| Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387 KPL-387, Placebo - Pericarditis, Pericarditis Acute | Phase 2 / Phase 3 | Recruiting | Kiniksa Pharmaceuticals International, plc | 325 | 2025-07-25 | 2026-10-19 |
| CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3) CardiolRx - Recurrent Pericarditis | Phase 3 | Recruiting | Cardiol Therapeutics Inc. | 110 | 2025-04-07 | 2026-09-10 |
| An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis VTX2735 - Recurrent Pericarditis | Phase 2 | Recruiting | Zomagen Biosciences Ltd. | 50 | 2025-01-28 | 2026-10-09 |
| COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable SUBPROTOCOL A, SUBPROTOCOL B, SUBPROTOCOL C - Cardiopulmonary Failure, Myocardial Infarction (MI) | Enrolling by invitation | Peerbridge Health, Inc | 15000 | 2024-11-16 | 2025-01-08 | |
| RUDRA Registry (Real-World Clinical Registry for Patients With Recurrent Pericarditis) Pericarditis | Active not recruiting | Eurasian Association of Therapists | 100 | 2024-09-30 | 2026-09-10 | |
| Pericardial Fluid Analysis in Recurrent Pericarditis Pericardiocentesis, Pericardiotomy, Cytofluorometry and Gene expression analysis - Acute Pericarditis, Pericardial Effusion | Enrolling by invitation | ASST Fatebenefratelli Sacco | 432 | 2024-08-18 | 2024-11-27 | |
| Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR) Observation - Inflammation, Cardiovascular Diseases | Not yet recruiting | King's College London | 1000 | 2024-07-01 | 2024-05-14 | |
| Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and Paragangliomas Cardiovascular Abnormalities, Arterial Blood Pressure | Enrolling by invitation | Laikο General Hospital, Athens | 50 | 2024-02-05 | 2026-01-05 | |
| Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels IL1RA Antibody Assay, suPAR Testing - Pericarditis | Unknown | ASST Fatebenefratelli Sacco | 146 | 2023-07-01 | 2024-07-03 | |
| Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children Anakinra, Prednisone - Pericarditis | Phase 3 | Unknown | Istituto Giannina Gaslini | 48 | 2023-06-01 | 2023-04-10 |
| MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study Stand of care ECG, Holter, MRI, ECHO, Quality of life questionnaire, Baseline Quality of Life questionnaire - Myocarditis, Myocarditis Acute | Unknown | Cardiology Research UBC | 500 | 2023-04-23 | 2023-10-26 | |
| A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine mRNA-1273 - Myocarditis, Pericarditis | Completed | ModernaTX, Inc. | 1169 | 2023-03-31 | 2025-08-01 |
Showing 20 of 54. Sign in to see all of them.
Myocarditis (14) · Recurrence (7) · Pericarditis, Constrictive (4) · Atrial Fibrillation (3) · Cardiomyopathies (3) · Cardiovascular Diseases (3) · Heart Diseases (3) · Heart Failure (3) · Myositis (3) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Arrhythmias, Cardiac (2) · Arthritis, Juvenile (2) · Arthritis, Rheumatoid (2) · Behcet Syndrome (2)
Cardiovascular Diseases (51) · Heart Diseases (51) · Pathological Conditions, Signs and Symptoms (18) · Pathologic Processes (16) · Cardiomyopathies (13) · Disease Attributes (9) · Vascular Diseases (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8) · Nervous System Diseases (8) · Respiratory Tract Diseases (7) · Genetic Diseases, Inborn (5) · Infections (5) · Musculoskeletal Diseases (5) · Myocardial Ischemia (5)
Colchicine (7) · Interleukin 1 Receptor Antagonist Protein (4) · WW Domain-Containing Oxidoreductase (3) · Observation (2) · Prednisolone (2) · rilonacept (2) · 2019-nCoV Vaccine mRNA-1273 (1) · Adrenal Cortex Hormones (1) · Aspirin (1) · COVID-19 Vaccines (1) · Caves (1) · Immune Checkpoint Inhibitors (1) · Immuvac (1) · Losartan (1) · Magnetic Resonance Imaging (1)
Azienda Sanitaria Locale 3, Torino (4) · Assistance Publique - Hôpitaux de Paris (3) · Kiniksa Pharmaceuticals International, plc (3) · ASST Fatebenefratelli Sacco (2) · Cardiol Therapeutics Inc. (2) · Kiniksa Pharmaceuticals (UK), Ltd. (2) · Ottawa Heart Institute Research Corporation (2) · R-Pharm International, LLC (2) · St. Vincent Cardiovascular Research Institute (2) · University of Cape Town (2) · Assiut University (1) · Azienda Ospedaliero, Universitaria Ospedali Riuniti (1) · Cardiologie et Développement (1) · Cardiology Research UBC (1) · Children's Healthcare of Atlanta (1)
United States (17) · Italy (13) · Canada (8) · France (6) · Greece (6) · Germany (5) · Spain (5) · Russia (3) · United Kingdom (3) · Poland (2) · Serbia (2) · South Africa (2) · Australia (1) · Austria (1) · Belgium (1)
Massimo Imazio, MD (2) · Mikhail Samsonov (2) · Parin J. Patel, MD (2) · Allen Klein, MD (1) · Antonio Abbate, MD, PhD (1) · Antonio L Brucato (1) · Antonio Luca Brucato, Prof. (1) · Barry Borlaug, MD (1) · Brian E Kogon, MD (1) · Bruce Carleton, PharmD (1) · Dimitris Tousoulis, Professor (1)
PMID 16186437, PMID 23040570, PMID 24508207, PMID 25172965, PMID 26228647, PMID 32081221, PMID 32553209, PMID 32720823, PMID 33270311, PMID 39044797, PMID 16026021, PMID 20805112, PMID 21873705, PMID 21884871, PMID 22090167, PMID 23992557, PMID 24694983, PMID 25178809, PMID 26320112, PMID 27825009, PMID 30613419, PMID 31610707, PMID 32398478, PMID 32866928, PMID 33229362, PMID 33882846, PMID 35383117, PMID 36250662, PMID 36316102, PMID 36599567, PMID 36740019, PMID 37163222, PMID 37380301, PMID 37587516, PMID 38471825, PMID 38883792, PMID 39022168, PMID 39045200, PMID 40569849, PMID 42207065, PMID 42432451, PMID 42533000, PMID 9045028
2025 (2), 1UL1TR001114-01 (1), 2018 (1)